*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| E269 - Hyperaldosteronism, unspecified - as a primary diagnosis code | E269 - Hyperaldosteronism, unspecified - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.51 | |
| Readmission Rate (%) | 22.65 | |
| Unplanned Readmission Rate (%) | 15.07 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 38,556 | |
| Total Hospitalizations with ICD E269 - Hyperaldosteronism, unspecified | 45 | |
| DRG Share of Total Hospitalizations | 0.12 | |
| % of Total ICD E269 - Hyperaldosteronism, unspecified in DRG | 58.44 | |
| Avg LOS at DRG | 4.31 | |
| Avg LOS with ICD E269 - Hyperaldosteronism, unspecified | 4.11 | |
| Readmission Rate at DRG | 23.27 | |
| Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 27.91 | |
| Unplanned Readmission Rate at DRG | 16.18 | |
| Unplanned Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | |
| Total Medicare payments at DRG | $249,025,224 | |
| Total Medicare payments with ICD E269 - Hyperaldosteronism, unspecified | $337,753 | |
| Total Medicare payment per Day at DRG | $1,499 | |
| Total Medicare payment per Day with ICD E269 - Hyperaldosteronism, unspecified | $1,826 | |
| Total Medicare payment per Hospitalization at DRG | $6,459 | |
| Total Medicare payment per Hospitalization with ICD E269 - Hyperaldosteronism, unspecified | $7,506 | |
| Total Medicare Charges at DRG | $1,257,184,982 | |
| Total Medicare Charges with ICD E269 - Hyperaldosteronism, unspecified | $1,543,719 | |
| Avg Charges at DRG | $32,607 | |
| Avg Charges with ICD E269 - Hyperaldosteronism, unspecified | $34,305 | |
| Mortality Rate at DRG | 0.35 | |
| Mortality Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | |
| SNF Discharge Rate at DRG | 21.19 | |
| SNF Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | |
| Home Discharge Rate at DRG | 48.47 | |
| Home Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 66.67 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,013,774 | ||||
| Total Hospitalizations with ICD E269 - Hyperaldosteronism, unspecified | 211 | ||||
| DRG Share of Total Hospitalizations | 3.08 | ||||
| % of Total ICD E269 - Hyperaldosteronism, unspecified in DRG | 4.82 | ||||
| Avg LOS at DRG | 5.34 | ||||
| Avg LOS with ICD E269 - Hyperaldosteronism, unspecified | 5.73 | ||||
| Readmission Rate at DRG | 28.25 | ||||
| Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 28.5 | ||||
| Unplanned Readmission Rate at DRG | 21.93 | ||||
| Unplanned Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 23.83 | ||||
| Total Medicare payments at DRG | $9,469,067,156 | ||||
| Total Medicare payments with ICD E269 - Hyperaldosteronism, unspecified | $2,093,249 | ||||
| Total Medicare payment per Day at DRG | $1,751 | ||||
| Total Medicare payment per Day with ICD E269 - Hyperaldosteronism, unspecified | $1,733 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,340 | ||||
| Total Medicare payment per Hospitalization with ICD E269 - Hyperaldosteronism, unspecified | $9,921 | ||||
| Total Medicare Charges at DRG | $43,343,716,813 | ||||
| Total Medicare Charges with ICD E269 - Hyperaldosteronism, unspecified | $9,126,135 | ||||
| Avg Charges at DRG | $42,755 | ||||
| Avg Charges with ICD E269 - Hyperaldosteronism, unspecified | $43,252 | ||||
| Mortality Rate at DRG | 3.72 | ||||
| Mortality Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | ||||
| SNF Discharge Rate at DRG | 20.84 | ||||
| SNF Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 15.17 | ||||
| Home Discharge Rate at DRG | 37.68 | ||||
| Home Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 50.71 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD E269 - Hyperaldosteronism, unspecified | 140 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD E269 - Hyperaldosteronism, unspecified in DRG | 3.2 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD E269 - Hyperaldosteronism, unspecified | 7.52 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 29.66 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 21.19 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD E269 - Hyperaldosteronism, unspecified | $1,646,528 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD E269 - Hyperaldosteronism, unspecified | $1,564 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD E269 - Hyperaldosteronism, unspecified | $11,761 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD E269 - Hyperaldosteronism, unspecified | $9,554,289 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD E269 - Hyperaldosteronism, unspecified | $68,245 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD E269 - Hyperaldosteronism, unspecified | 7.86 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 30.0 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 27.14 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 38,556 | ||||
| Total Hospitalizations with ICD E269 - Hyperaldosteronism, unspecified | 67 | ||||
| DRG Share of Total Hospitalizations | 0.12 | ||||
| % of Total ICD E269 - Hyperaldosteronism, unspecified in DRG | 1.53 | ||||
| Avg LOS at DRG | 4.31 | ||||
| Avg LOS with ICD E269 - Hyperaldosteronism, unspecified | 4.27 | ||||
| Readmission Rate at DRG | 23.27 | ||||
| Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 27.69 | ||||
| Unplanned Readmission Rate at DRG | 16.18 | ||||
| Unplanned Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 20.0 | ||||
| Total Medicare payments at DRG | $249,025,224 | ||||
| Total Medicare payments with ICD E269 - Hyperaldosteronism, unspecified | $483,217 | ||||
| Total Medicare payment per Day at DRG | $1,499 | ||||
| Total Medicare payment per Day with ICD E269 - Hyperaldosteronism, unspecified | $1,690 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,459 | ||||
| Total Medicare payment per Hospitalization with ICD E269 - Hyperaldosteronism, unspecified | $7,212 | ||||
| Total Medicare Charges at DRG | $1,257,184,982 | ||||
| Total Medicare Charges with ICD E269 - Hyperaldosteronism, unspecified | $2,355,544 | ||||
| Avg Charges at DRG | $32,607 | ||||
| Avg Charges with ICD E269 - Hyperaldosteronism, unspecified | $35,157 | ||||
| Mortality Rate at DRG | 0.35 | ||||
| Mortality Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | ||||
| SNF Discharge Rate at DRG | 21.19 | ||||
| SNF Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | ||||
| Home Discharge Rate at DRG | 48.47 | ||||
| Home Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 64.18 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 615: ADRENAL AND PITUITARY PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 885: PSYCHOSES | DRG 304: HYPERTENSION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD E269 - Hyperaldosteronism, unspecified | 54 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD E269 - Hyperaldosteronism, unspecified in DRG | 1.23 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD E269 - Hyperaldosteronism, unspecified | 5.24 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | 25.49 | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD E269 - Hyperaldosteronism, unspecified | $477,198 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD E269 - Hyperaldosteronism, unspecified | $1,686 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD E269 - Hyperaldosteronism, unspecified | $8,837 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD E269 - Hyperaldosteronism, unspecified | $2,331,707 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD E269 - Hyperaldosteronism, unspecified | $43,180 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD E269 - Hyperaldosteronism, unspecified | NA | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 20.37 | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD E269 - Hyperaldosteronism, unspecified | 40.74 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| BAPTIST MEDICAL CENTER JACKSONVILLE | 800 PRUDENTIAL DR | JACKSONVILLE | FL | 32207 | 36 |
| BAYLOR SCOTT & WHITE MEDICAL CENTER - TEMPLE | 2401 S 31ST ST | TEMPLE | TX | 76508 | 23 |
| THE JOHNS HOPKINS HOSPITAL | 600 N WOLFE ST | BALTIMORE | MD | 21287 | 22 |